| Certification: | GMP |
|---|---|
| Grade Standard: | Medicine Grade |
| Type: | API |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Lincomycin hydrochloride This remarkable pharmaceutical compound manifests as a pristine white crystalline powder at ambient conditions, boasting a subtle yet distinct aroma and an undeniably bitter taste. With its solubility in water and methanol, Lincomycin Hydrochloride is frequently utilized in its hydrochloride salt form for feed applications. As a member of the lincosamides family, this alkaline antibiotic is sourced from the distinguished Streptomyces lincolnensis, showcasing its natural origin and potent capabilities.
| Basic Information | |
| Product name | Lincomycin Hydrochloride |
| Grade | Pharmaceutical Grade |
| Appearance | White crystal powder |
| Assay | 99% |
| Shelf life | 3 Years |
| Packing | 25kg/drum |
| Condition | stored in a cool and dry place |
Primarily, Lincomycin Hydrochloride is adept at combating infections instigated by Gram-positive bacteria, especially those resilient to penicillin. It is an exceptional remedy for poultry respiratory ailments triggered by Mycoplasma, swine enzootic pneumonia, and anaerobic infections such as chicken necrotizing enterocolitis.
Beyond these applications, it extends its therapeutic prowess to tackle treponema dysentery, toxoplasmosis, and actinomycosis afflictions in dogs and cats, providing a reliable solution for these challenging conditions.
Lincomycin stands out as a lincosamide antibiotic, sourced from the venerable actinomyces Streptomyces lincolnensis. Notably, its derivative, clindamycin, is achieved by substituting the 7-hydroxy group with an atom, accompanied by a chirality inversion, showcasing advanced biochemical innovation.
While sharing structural, antibacterial, and mechanistic parallels with macrolides, Lincomycin asserts its competence against a broader spectrum, including actinomycetes, mycoplasma, and certain Plasmodium species. A singular intramuscular injection of 600 mg yields an impressive peak serum concentration of 11.6 micrograms/ml at 60 minutes, maintaining effective levels for up to 20 hours, targeting most susceptible gram-positive organisms. Post-administration urinary excretion varies between 1.8 to 24.8 percent, with an average of 17.3 percent.
1. Tailored oral formulations of Lincomycin Hydrochloride are ideal for addressing respiratory, abdominal, and female reproductive tract infections, as well as pelvic, skin, and soft tissue infections caused by sensitive strains of Staphylococcus aureus and Streptococcus pneumoniae.
2. For more severe infections, injectable formulations offer enhanced efficacy against streptococcal, pneumococcal, and staphylococcal pathogens. These are particularly valuable in surgical adjuvant therapies for septicemia, bone and joint infections, chronic conditions, and acute hematogenous osteomyelitis induced by Staphylococcus.
3. The versatile Lincomycin Hydrochloride also caters to patients with penicillin allergies or intolerance, offering a critical alternative for treating infectious diseases where penicillin use is not feasible.
){kind=link}